In low and middle income countries diagnostic, financial and infrastructural constraints mean the risk of emerging antimicrobial resistance is high. This can lead to excessive or inappropriate use of anti-infectives, and so the implementation of appropriate policies to regulate their use and curb the emergence of resistant microbial threats is consequently more important now than ever. As recognised in the Goal 3 of the WHO's Sustainable Development Goals, concerted effort is required to tackle this threat, and to highlight the challenges and developments within antimicrobial drug policies in low and middle income countries.
Aims and Scope
We are proud to present a cross-journal series to highlight the challenges and developments made within antimicrobial drug policies in low and middle income countries. We invited both reviews and original research to bring together articles on this topic in one place articles.
The following journals participated in this collection:
Antimicrobial Resistance & Infection Control
Journal of Pharmaceutical Policy and Practice
Global Health Research and Policy
Infectious Diseases of Poverty